Smruti K. Patel · An International Delphi Consensus on Defining the Optimal Surgical Composite Outcome in Metastatic Spine Disease
Follow
Article1 min read·Published Nov 2025

An International Delphi Consensus on Defining the Optimal Surgical Composite Outcome in Metastatic Spine Disease

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Nov 2025 · 1 min read

In brief

In brief

International spine oncology experts achieved consensus on a composite outcome measure (OSCO-M) for evaluating surgical success in metastatic spine disease patients. The measure incorporates absence of severe adverse events, functional outcomes, and quality-of-care indicators to provide multidimensional assessment of surgical interventions in this complex patient population.

Written by the GCMD Library team from the article.

Smruti K. Patel

Study Design: Delphi consensus. Objective: To define an optimal surgical composite outcome measure in patients with metastatic spine disease (OSCO-M) through international consensus among key opinion leaders. Materials And Methods: Members of the AO Spine Knowledge Forum Tumor, an international group of dedicated spine oncology surgeons and oncologists, participated in a modified Delphi process between March 2023 and November 2024. The study was conducted in 2 parts. The first part aimed on identifying which outcome variables were deemed important to be included in the composite outcome. The second part focused on the definition of a successful outcome with regards to the agreed variables from Part 1. Each part consisted of a questionnaire and a consensus meeting. Consensus was achieved when a threshold of 70% agreement was reached. Results: A total of 42 dedicated spine oncology surgeons and oncologists from North America, Latin America, Europe, and Asia participated. Over 87% of respondents agreed that composite measures reflect the multidimensional aspect of the surgical process more than an individual outcome variable. Most respondents (93%) agreed/strongly agreed that composite measures should be used to assess the quality of surgical care in spine oncology. Through consensus, the following three outcome variables were selected to define the OSCO-M: the absence of SAVES-V2 (Spinal Adverse Events Severity System, Version 2) grade 3 adverse events or higher within 30 days

Statements in this article

  1. Composite measures reflect the multidimensional aspect of the surgical process more than an individual outcome variable in spine oncology.

    EstablishedResults
  2. Composite measures should be used to assess the quality of surgical care in spine oncology.

    RecommendationResults
  3. The optimal surgical composite outcome in metastatic spine disease (OSCO-M) is defined by the absence of SAVES-V2 grade 3 adverse events or higher within 30 days.

    GuidelineResults

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.